Put the Efficacy and Safety of Overactive Bladder Meds Into Perspective

May 2017

You'll see fewer payers requiring a trial of immediate-release oxybutynin for overactive bladder before approving an alternative.

Oxybutynin IR has been the least expensive...but the cost of some of the other antimuscarinics are coming down as more of them go generic.

For mild symptoms of overactive bladder, stick with nondrug measures first...limiting caffeine, bladder training, etc. Explain these strategies can work as well as meds...if patients are diligent.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Cholesterol Continue to Expect a Limited Role for PCSK9 Inhibitors
Pregnancy Watch for Oral Antibiotics to Avoid During Pregnancy
Oral Health Don't Use Antibiotic Prophylaxis Prior to Dental Procedures for Most Patients
HIV & AIDS Know What to Watch for With Complex Regimens in Hospitalized HIV Patients
Gastroenterology Steer Clear of Viberzi in Patients Who Don't Have a Gallbladder
Back Pain Don't Rely on Acetaminophen for Chronic Low Back Pain
Antithrombotics Consider Anticoagulants After Intracranial Hemorrhage in Some A Fib Patients
Overactive Bladder Put the Efficacy and Safety of Overactive Bladder Meds Into Perspective
Respiratory & Allergy Help Patients Know the Differences Among OTC Oral Antihistamines
Cardiology Don't Rely on Fish Oil Supplements to Reduce CV Risk
Rosacea Save Rhofade or Mirvaso for Rosacea Patients With Persistent Facial Redness

Put the Efficacy and Safety of Overactive Bladder Meds Into Perspective

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents